Friday's NASDAQ Top % Gainers: SBSA, PNBC, CYBI, HZNP

New York, NY - April 02, 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Friday March 30th. The Nasdaq Composite ended lower by 3.79 (-0.12%) to close at 3,091.57.

Spanish Broadcasting System Inc. (NASDAQ:SBSA) shares rose 43.31% and closed at $6.75 on Friday's trading session after the company reported fourth-quarter income of $3.68 million or $0.51 per share, from $880 thousand or $0.12 per share in the year ago quarter owing to an increase in net revenues. Consolidated net revenue totaled $38.2 million, as compared to $34.9 million for the same prior year period.

The company had earlier in the month of February closed the offering of $275 million in aggregate principal amount of 12.5% senior secured notes due 2017 at an issue price of 97% of the principal amount.

Princeton National Bancorp, Inc. (NASDAQ:PNBC) stock soared 25.51% and closed at $3.69. The company reported fourth-quarter net loss of $28.61 million or $8.58 per share, as compared to a loss of $16.07 million or $4.85 per share in the same quarter last year.Net interest income declined to $8.21 million, as against $9.42 million in the prior year quarter.

For fiscal 2011, the company's net interest margin increased to 4.08%, as compared to 3.98% for 2010, despite the impact of a high level of non-accrual loans, a decrease in loans from the lack of sufficient quality loan demand and the historically low interest rate environment.

Cybex International, Inc. (NASDAQ:CYBI) made a new 52 week high at $3.60 and closed at $2.53 Friday , up 13.45% without any official news. In the last year, the company has gained over 200%. The Company develops, manufactures and markets strength and cardiovascular fitness equipment products for the commercial and consumer markets.

Horizon Pharma Inc (NASDAQ:HZNP) shares climbed 12.20% and closed at $4.14 in Friday's trading session. The company had has filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Par Pharmaceutical and related to an Abbreviated New Drug Application that Par filed with the U.S. Food and Drug Administration to market a generic version of DUEXIS(R) tablets.

Get Free investor news and stock alerts at Investorideas.com

Sign Up: http://www.investorideas.com/Resources/Newsletter.asp

Join Investor Ideas Get 13 of the best stock directories online;

Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks (over 1300 green stocks in directory) and more

Join: http://www.investorideas.com/membership/

About InvestorIdeas.com:

InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas

Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp

800-665-0411 - Source - www.Investorideas.com